In vitro activity of HSR-903, a new quinolone

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1326-1330

  Takahashi, Yoshie ^a,b   Masuda, Nobuhisa ^a   Otsuki, Masako ^a   Miki, Megumi ^a   Nishino, Takeshi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b Abbott Japan Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 7 (7 AMINO 5 AZASPIRO[2.4]HEPT 5 YL) 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 8 METHYL 4 OXO 3 QUINOLINECARBOXYLIC ACID; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); LEVOFLOXACIN; LOMEFLOXACIN; QUINOLONE DERIVATIVE; SPARFLOXACIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; DNA SUPERCOILING; DRUG POTENCY; ENTEROBACTERIACEAE; ENTEROCOCCUS; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PYOGENES;

EID: 0030943596     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1326     Document Type: Article

References (19)

1. Blumberg, H. M., D. J. Carroll, P. Terry, and I. K. Wachsmuth. 1991. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J. Infect. Dis. 163:1279-1285.
2. Craig, W. A., and S. Gudmundsson. 1991. The postantibiotic effect, p. 403-431. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, Md.
3. Domagala, J. M. 1994. Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J. Antimicrob. Chemother. 33:707-720.
4. Fujimaki, K., T. Noumi, I. Saikawa, M. Inoue, and S. Mitsuhashi. 1988. In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone. Antimicrob. Agents Chemother. 32:827-833.
5. Hirose, T., E. Okezaki, H. Kato, Y. Ho, M. Inoue, and S. Mitsuhashi. 1987. In vitro and in vivo activity of NY-198, a new difluorinated quinolone. Antimicrob. Agents Chemother. 31:854-859.
6. Kaatz, G. W., S. M. Seo, and C. A. Ruble. 1991. Mechanisms of fluoroquinolone resistance in Staphylococcus aureus. J. Infect. Dis. 163:1080-1086.
7. Kojima, T., M. Inoue, and S. Mitsuhashi. 1989. In vitro activity of AT-4140 against clinical bacterial isolates. Antimicrob. Agents Chemother. 33:1980-1988.
8. Mitscher, L. A., P. Devasthale, and R. Zavod. 1993. Structure-activity relationships, p. 3-51. In D. C. Hooper and J. S. Wolfson (ed.), Quinolone antibacterial agents, 2nd ed. American Society for Microbiology, Washington, D.C.
9. Murata, M., E. Takahara, O. Nagata, H. Kato, I. Tamai, and A. Tsuji. 1995. Carrier-mediated tissue distribution and pharmacokinetics of HSR-903, a new quinolone, abstr. F203, p. 148. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Ng, E. Y. W., M. Trucksis, and D. C. Hooper. 1994. Quinolone resistance mediated by norA: physiologic characterization and relationship flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrob. Agents Chemother. 37:1345-1355.
11. Norrby, S. R., and M. Jonsson. 1988. Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative. Antimicrob. Agents Chemother. 32:1278-1281.
12. Okezaki, E., Y. Watanabe, T. Hirose, T. Yoshida, Y. Aoki, and H. Kato. 1995. Antibacterial activity of HSR-903, a new novel quinolone, abstr. F202, p. 148. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Otter, R., and N. R. Cozzarelli. 1983. Escherichia coli DNA gyrase. Methods Enzymol. 100:171-180.
14. Sato, K., Y. Matsuura, M. Inoue, T. Une, Y. Osada, H. Ogawa, and S. Mitsuhashi. 1982. In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob. Agents Chemother. 22:548-553.
15. Tanaka, M., M. Otsuki, T. Une, and T. Nishino. 1990. In vitro and in vivo activity of DR-3355, an optically active isomer of ofloxacin. J. Antimicrob. Chemother. 26:659-666.
16. Tanaka, M., Y. X. Zhang, H. Ishida, T. Akasaka, K. Sato, and I. Hayakawa. 1995. Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China. J. Med. Microbiol. 42:214-219.
17. Une, T., T. Fujimoto, K. Sato, and Y. Osada. 1988. In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob. Agents Chemother. 32: 1336-1340.
18. Wise, R., J. M. Andrews, and L. J. Edwards. 1983. In vitro activity of Bay 09867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrob. Agents Chemother. 23:559-564.
19. Yoshida, H., M. Bogaki, S. Nakamura, K. Ubukata, and M. Konno. 1990. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172:6942-6949.